Carcinoembryonic Antigen (CEA)

ebn benghazi

Carcinoembryonic Antigen (CEA)

Carcinoembryonic antigen (CEA) is normally found in small amounts in the blood of most healthy people, but may become elevated in people who have cancer or some benign conditions. The primary use of CEA is in monitoring colorectal cancer, especially when the disease has spread (metastasized). CEA is also used after treatment to check for recurrence of colorectal cancer. However, a wide variety of other cancers can produce elevated levels of this tumor marker, including melanoma; lymphoma; and cancers of the breast, lung, pancreas, stomach, cervix, bladder, kidney, thyroid, liver, and ovary.
Elevated CEA levels can also occur in patients with noncancerous conditions, including inflammatory bowel disease, pancreatitis, and liver disease. Tobacco use can also contribute to higher-than-normal levels of CEA.
Medical Editorial Information

This article is provided for educational and laboratory-medicine information. Clinical decisions should be based on the patient context, current evidence, and guidance from a qualified healthcare professional.

Author: ebn benghazi Published: 2010-12-29T13:21:00-08:00
Explore this topic
Knowledge map

Post a Comment

Cookie Consent
This website uses cookies to analyze traffic, remember your preferences, and improve your browsing experience.
Oops!
It looks like there is a problem with your internet connection. Please check your connection and try again.
AdBlock Detected!
لقد اكتشفنا أنك تستخدم إضافة حظر الإعلانات في متصفحك.
الإيرادات التي نحصل عليها من الإعلانات تُستخدم لإدارة هذا الموقع، نطلب منك إضافة موقعنا إلى قائمة الاستثناءات في إضافة حظر الإعلانات الخاصة بك.